110
29
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T36356 |
T-Peptide
|
||
Highly neurotoxic cell-permeable analog of PHF6. Induces aggregation of Tau peptides. | |||
TP1785L |
Peptide T acetate(106362-32-7 free base)
|
Others; HIV Protease | Microbiology/Virology; Others; Proteases/Proteasome |
Peptide T acetate(106362-32-7 free base) 是一种来自 HIV-1 gp120 V2 区域的八肽。它是一种合成八肽,其可能的作用机制是 gp120 对 CD4 受体的竞争性抑制以及与血管肠肽受体的结合和抑制细胞因子作用。 | |||
TP1653L |
SV40 T-Ag-derived NLS peptide acetate
SV40 T-Ag-derived NLS peptide acetate(105425-98-7 free base) |
Others | Others |
SV40 T-Ag-derived NLS peptide acetate (SV40 T-Ag-derived NLS peptide acetate)(105425-98-7 free base) 是一种核定位信号肽。用这种肽标记的 DNA 可以有效地转移到细胞核中。 | |||
TP1785 |
Peptide T
|
||
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and in | |||
TP1805 |
T7 Tag Peptide
|
||
T7 Tag Peptide 是一个由T7噬菌体编码的蛋白p10前导序列的11个氨基酸标记蛋白,可以被T7 tag标签抗体特异性识别,可用于不同的免疫检测以及亲和纯化。 | |||
TP1873 |
Peptide T TFA
|
||
Peptide T (TFA) is an octapeptide derived from the V2 region of HIV-1 gp120. It serves as a ligand for the CD4 receptor, effectively inhibiting the binding of HIV to the CD4 receptor. | |||
TP2401 |
Peptide T amide
D-Ala(1)-peptide T amide |
||
Peptide T amide is an octapeptide segment of HIV envelope gp120 and is used in AIDS therapy. | |||
T7624 |
DAPTA
DAPTA(TFA),D-Ala-peptide T-amide,Adaptavir |
HIV Protease; CCR | Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
DAPTA (Adaptavir) 是一种合成肽,是 CCR5抑制剂,有抗 HIV 的活性。 | |||
TP1653 |
SV40 T-Ag-derived NLS peptide
|
||
This peptide, a nuclear localization signal DNA tagged to this peptide efficiently translocates into the cell nucleus. | |||
T4422 |
Edonerpic maleate
T-817MA,T-817 maleate |
Beta Amyloid | Neuroscience |
Edonerpic maleate (T-817 maleate) 是新神经营养剂,对淀粉样蛋白 β 肽具有抑制作用。 | |||
T77792 |
HIV Peptide T
|
Others | Others |
HIV Peptide T(Peptide T),这种合成的八肽是HIV感染治疗中的一种抗病毒药物,其主要通过竞争性抑制gp120(HIV表面蛋白)与CD4受体的相互作用,同时与血管肠肽(vasointestinal peptide, VIP)受体同源结合并且阻断细胞因子的产生与作用来发挥功效。 | |||
TP1541L |
BDC2.5 mimotope 1040-31 acetate
BDC2.5 mimotope 1040-31 acetate(329696-49-3 free base) |
Others | Others |
BDC2.5 mimotope 1040-31 acetate(329696-49-3 free base) 一种用于致糖尿病 T 细胞克隆 BDC2.5 的有效激动肽 (mimotope)。它可以刺激 BDC2.5 细胞,使细胞对这种模拟表位表现出良好的反应。 1040-31 肽对 BDC2.5 TCR Tg+(转基因)T 细胞具有特异性。该肽也称为 p31。 | |||
TP1600L |
Iα52 acetate(137756-45-7 free base)
|
Others | Others |
Iα52 acetate(137756-45-7 free base) 是一种天然加工的肽,包含鼠 I-Eα 链的 52-68 位残基,可能有助于选择未成熟的 T 细胞。 | |||
TP1735L |
Influenza HA 126-138 acetate
Influenza HA 126-138 acetate(207349-63-1 free base) |
Others | Others |
Influenza HA 126-138 acetate 是一种流感病毒血凝素 (HA) 肽乙酸盐,包含氨基酸 126-138。 它诱导胸腺和外周 T 细胞凋亡。 | |||
T6941 |
PI-1840
PI 1840 |
PARP; Proteasome | Chromatin/Epigenetic; DNA Damage/DNA Repair; Proteases/Proteasome; Ubiquitination |
PI-1840 是一种高效的、选择性的蛋白酶体chymotrypsin-like (CT-L)抑制剂,IC50=27nM。 | |||
TP1606L |
NLS PKKKRKV acetate(95088-49-6 free base)
|
Others | Others |
NLS PKKKRKV acetate(95088-49-6 free base) 是从大猿病毒40肿瘤抗原(SV40大T 抗原)衍生的肽,是基因转移研究领域中增强核入口的一种方法。 | |||
T21618L |
Myelin Basic Protein (87-99) Acetate
Myelin Basic Protein (87-99) Acetate (118506-26-6 Free base) |
Others | Others |
Myelin Basic Protein (87-99) Acetate (Myelin Basic Protein (87-99) Acetate (118506-26-6 Free base)) 是一种致脑炎肽,可诱导碱性蛋白特异性 T 细胞增殖。 它导致外周血单核细胞中的 Th1 极化,这与多发性硬化症 (MS) 有牵连。 | |||
T7657 |
MOG (35-55) mouse, rat
髓鞘少突胶质细胞糖蛋白,MOG (35-55) |
Others | Others |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55)) 是中枢神经鞘的一个次要成分。它能诱导强效的 T 细胞和 B 细胞反应,同时是高度脑源性的。它能够引发复发缓解性神经系统疾病,伴有广泛的斑块样脱髓鞘。 | |||
T7657L |
MOG peptide (35-55) , mouse, rat acetate
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat acetate,MOG peptide (35-55) , mouse, rat acetate (149635-73-4 Free base) |
Others | Others |
Myelin Oligodendrocyte Glycoprotein (MOG) peptide (35-55) , mouse, rat acetate 是MOG peptide (35-55)衍生物。 MOG peptide (35-55)是髓鞘少突胶质细胞糖蛋白 (MOG) 免疫原肽的 一部分。MOG peptide (35-55) 特异性作用于 CD4+ T 细胞,能够给诱导实验性自身免疫性脑脊髓炎 (EAE) 动物模型。MOG peptide (35-55) , mouse, rat acetate(149635-73-4 Free base)是MOG peptide (35-55)衍生物。 MOG peptide (35-55)是髓鞘少突胶质细胞糖蛋白 (MOG) 免疫原肽的 一部分,可用于研究与免疫相关的疾病。 | |||
TP1543L |
G280-9 acetate(156761-76-1 free base)
|
Others | Others |
G280-9 acetate(156761-76-1 free base) 是一种常见的黑色素瘤 gp100 表位,受 MHC 相关 HLA-A2 限制。 G280-9 序列是独特的,因为它可以在非常低的浓度下被细胞毒性 T 淋巴细胞识别,但是它显示出低的总免疫原性,这可能是由于该肽对 HLA-A2 的亲和力相对较低。 | |||
T40511 |
TET 830 modified/T-helper epitope from tetanus toxoid
|
||
TET 830 modified/T-helper epitope from tetanus toxoid is a T-cell stimulating peptide derived from tetanus toxoid. It acts as a helper peptide in vaccinations, eliciting T-cell responses. | |||
TP2402 |
Peptide VF13N
Epitope VF13N |
||
Peptide VF13N is a synthetic rabies virus glycoprotein T helper cell epitope. | |||
TP1679 |
BDC2.5 mimotope 1040-51
|
||
BDC2.5 mimotope 1040-51 is a mimotope peptide for diabetogenic T cell clone BDC2.5. isolated from non-obese diabetic mice.This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. from non-obese diabetic (NOD) mice. T cells | |||
TP1541 |
BDC2.5 mimotope 1040-31
|
||
This is a effectively agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. It can stimulate BDC2.5 cells with cells showing good response to this mimotope. 1040-31 peptide is specific for BDC2.5 TCR Tg+ (transgenic) T cells. This peptide is | |||
TP1612 |
OVA sequence (323-336)
OVA sequence 323-336 |
||
This peptide is a cognate helper T-lymphocyte peptide that is employed to enhance CTL epitope immunogencity | |||
TP1830 |
SV40 large T antigen NLS
|
||
SV40 large T antigen NLS is from Large T antigen residue 47 to 55, enables protein import into cell nucleus. This peptide is generated from Large T antigen residue 47 to 55. | |||
T40132 |
Insulin β Chain Peptide (15-23)
|
||
Insulin β Chain Peptide (15-23), also referred to as INS, is an insulin-derived peptide that is specifically recognized by islet-associated T cells. The tetramer of Insulin β Chain Peptide (15-23) effectively stained the INS-reactive CTL clone G9C8; however, neither this tetramer nor the negative control tetramer (TUM) exhibited staining on the splenic CD8+ T cells obtained from NOD or 8.3-TCRαβ transgenic NOD mice. | |||
T80979 |
T-kinin
Ile-Ser-bradykinin |
||
T-kinin (Ile-Ser-bradykinin) 是一种涉及炎症研究的缓激肽类肽。 | |||
TP1601 |
BDC2.5 mimotope 1040-31 TFA(329696-49-3 free base)
BDC2.5 mimotope 1040-31 TFA |
||
This is a strongly agonistic peptide (mimotope) for diabetogenic T cell clone BDC2.5. | |||
T82908 |
BDC2.5 mimotope 1040-31 TFA
|
||
BDC2.5 mimotope 1040-31 TFA,一种针对糖尿病T细胞克隆BDC2.5的强活性激动肽,具备对BDC2.5 TCR Tg+T细胞的高度特异性。 | |||
TP1588 |
Tetanus toxin (830-843)
Tetanus toxin 830-843 |
||
Tetanus toxin (830-843) from tetanus toxoid is a universal human tetanus toxin T cell epitope. It induces T-cell activation and is used as a helper peptide in vaccinations. | |||
T81011 |
Tetanus Toxin (830–844)
|
||
Tetanus Toxin (830–844) 是具有生物活性的肽类化合物。它是破伤风毒素衍生的 TT830–844 CD4+ T 细胞表位,能与多种 HLA-DRB 分子结合。该 CD4+ T 细胞表位由于与广泛的 HLA-DRB 分子具有亲和力,有潜力在大范围人群中诱发 CD4+ T 细胞应答。 | |||
T78000 |
OVA Peptide (323-339)
|
||
OVA Peptide (323-339) 是卵清蛋白(OVA)的T和B细胞表位,对BALB/c小鼠的瞬时超敏反应生成与发展至关重要。 | |||
TP1600 |
Iα52
|
||
Iα52 is a naturally occurring peptide derived from the murine I-Eα chain, specifically from residues 52 to 68. It is involved in the selection process of immature T cells. | |||
TP2183 |
Large T antigen - rhesus polyomavirus 560-568
|
Others | Others |
Large T antigen - rhesus polyomavirus 560-568 has a peptide sequence of Ser-Glu-Phe-Leu-Leu-Glu-Lys-Arg-Ile. T antigen is required for viral DNA replication, transcription, and virion assembly. | |||
T81513 |
Peptide A5K acetate
|
||
Peptide A5K acetate 是 INF7-TAT 衍生物,专用于 CRISPR RNP 传递到 T 细胞。该化合物有效增强 Cas9 RNP 传递到自然杀伤 (NK) 细胞的能力。 | |||
T75244 |
Acyline TFA
|
||
Acyline TFA,GnRH 多肽类似物,是一种GnRH 拮抗剂,可以抑制促性腺激素和睾酮 (T) 水平。 | |||
TP1743 |
MPG, HIV related
|
||
MPG, a 27-amino acid peptide compound, is derived from the fusion peptide domain of HIV-1 gp41 and the nuclear localisation sequence of SV40 large T antigen. As a potent delivery agent, MPG enables efficient and widespread transport of nucleic acids and oligonucleotides into cultured cells. | |||
TP1735 |
Influenza HA (126-138)
Influenza HA 126-138 |
||
Influenza HA (126-138) is a peptide derived from the hemagglutinin (HA) protein of the influenza virus. It consists of amino acids 126-138 and has the ability to induce apoptosis in both thymic and peripheral T-cells. | |||
T76382 |
Hemagglutinin (48-68)
|
||
Hemagglutinin (48-68) 为流感病毒血凝素的48至68片段,能够诱导肽特异性T细胞克隆增殖。 | |||
T82179 |
HOXB7 8–25
MDM2 32-46 |
Others | Others |
HOXB7 8–25 (MDM2 32-46)为来源于MDM2的肽段,能够特异性诱导抗原和激活肿瘤反应性的CD4+ T细胞。 | |||
T83852 |
EGFRvIII Peptide TFA
PEGFRvIII (9-mer),Epidermal Growth Factor Receptor Variant III Peptide |
||
EGFRvIII peptide是一种合成肽,对应于特异性肿瘤、具有持续激活性的EGFR变体EGFRvIII的融合接头,该变体缺少野生型EGFR的第6至273个氨基酸。在25 µg/ml的浓度下,它能与MHC I类亚型HLA-A*0201阳性的T2细胞结合。在用于分离的人外周血单个核细胞(PBMCs)衍生的树突状细胞中,EGFRvIII peptide可诱导抗原呈递,进而刺激CD8+细胞毒性T淋巴细胞的激活和IFN-γ产生。与toll样受体5(TLR5)激动剂鞭毛蛋白B共同免疫EGFRvIII peptide(15 µg/动物),在正交GL261胶质母细胞瘤小鼠异种移植模型中,增加了CD8+ T细胞数量,减少了调节性T细胞(Tregs)数量,减少了肿瘤体积,并提高了生存率。 | |||
T25051 |
Allotrap
Peptide Bc-1nl |
Others | Others |
Allotrap is a small synthetic peptide derived from the alpha1 helix of the heavy chain of HLA class I proteins. It suppresses human T cell responses in vitro. It prolongs allograft survival in rats and mice. | |||
T39863 |
LCMV GP (61-80)
|
||
LCMV GP (61-80) is a peptide fragment derived from LCMV glycoprotein (GP) and corresponds to amino acids 61-80. This specific epitope, LCMV GP (61-80), has the ability to elicit CD4+ T-cell response. | |||
T82743 |
CFP10 (71–85)
|
||
CFP10 (71–85) 是具生物活性的肽类,能激活表达不同MHC II类与I类分子的人类CD4+和CD8+ T细胞,诱导IFN-γ产生及CTL活性。(CFP10 71–85). | |||
TP1621 |
Insulin alpha-chain (1-13)
Insulin alpha-chain 1-13 |
||
This peptide is a fragment of the alpha-chain of insulin amino acids 1 to 13. The insulin a-chain epitope recognized by human T cells is posttranslationally modified. | |||
T38687 |
Influenza Matrix Protein (61-72)
|
||
Influenza Matrix Protein (61-72) is a peptide derived from the matrix protein of influenza viruses and encompasses amino acids 61-72. This specific epitope, Influenza Matrix Protein (61-72), has the ability to elicit a CD4+ T-cell response. | |||
TP1339 |
OVA Peptide 323-339
|
||
OVA Peptide (323-339) represents a T and B cell epitope of Ovalbumin (Ova), which play an important role in the development and development of immediate hypersensitivity in BALB/c mice. | |||
TP1588L |
Tetanus toxin 830-843 acetate
Tetanus toxin 830-843 acetate(119260-99-0 free base) |
Others | Others |
Tetanus toxin 830-843 acetate (Tetanus toxin 830-843 acetate (119260-99-0 free base)) 来自破伤风类毒素的醋酸破伤风毒素(830-843) 是一种通用的人类破伤风毒素 T 细胞表位。它诱导 T 细胞活化并在疫苗接种中用作辅助肽。 | |||
TP1629 |
LCMV gp33-41 (TFA) (151705-84-9 free base)
LCMV gp33-41 (TFA) |
||
LCMV gp33-41 (TFA), the carboxyl-extended 11-aa-long peptide, is an lymphocytic choriomeningitis virus sequence restricted by MHC class I H-2Db molecules and presented to cytotoxic T lymphocytes[1]. |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04779 |
BTN3A2 Protein, Human, Recombinant (His)
BTF3,BT3.2,BTF4,BTN3.2,C... |
Human | HEK293 Cells |
The three butyrophilin BTN3A molecules, BTN3A1, BTN3A2, and BTN3A3, are members of the B7/butyrophilin-like group of Ig superfamily receptors, which modulate the function of T cells. BTN3A2 is overexpressed in gastric tumors, and deletion of BTN3A2 inhibited proliferation, migration, and invasion of gastric cancer cells. The butyrophilin 3 (BTN3) receptors are implicated in the T lymphocytes regulation and present a wide plasticity in mammals. A thorough phylogenetic analysis reveals a concerted... | |||
TMPK-01350 |
CD3 epsilon/CD3e 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi)
CD3E,T3E,FLJ18683,CD3-ε,CD3E/CD3 ε 1-27 pept |
Cynomolgus | HEK293 Cells |
CD3E, is a single-pass type I membrane protein.CD3 (cluster of differentiation 3) T cell co-receptor helps to activate both the cytotoxic T cell (CD8 naive T cells) and also T helper cells (CD4 naive T cells). It consists of a protein complex and is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. CD3 epsilon/CD3e 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi) is expressed in HEK293 mammalian cells with C-hFc-Avi tag. ... | |||
TMPK-01351 |
CD3 epsilon/CD3e epsilon 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi), Biotinylated
TCRE,FLJ18683,T3E,CD3E,CD3-epsilon,CD3E/CD... |
Cynomolgus | HEK293 Cells |
CD3E, is a single-pass type I membrane protein.CD3 (cluster of differentiation 3) T cell co-receptor helps to activate both the cytotoxic T cell (CD8 naive T cells) and also T helper cells (CD4 naive T cells). It consists of a protein complex and is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. CD3 epsilon/CD3e epsilon 1-27 peptide Protein, Cynomolgus, Recombinant (hFc & Avi), Biotinylated is expressed in HEK293 mammalian cell... | |||
TMPK-00095 |
CD3 epsilon/CD3e 1-27 peptide Protein, Human, Recombinant (hFc & Avi)
CD3-epsilon,IMD18,T3E,CD3-ε,CD3E/CD3 ε 1-27 pep... |
Human | HEK293 Cells |
CD3E, is a single-pass type I membrane protein.CD3 (cluster of differentiation 3) T cell co-receptor helps to activate both the cytotoxic T cell (CD8 naive T cells) and also T helper cells (CD4 naive T cells). It consists of a protein complex and is composed of four distinct chains. In mammals, the complex contains a CD3γ chain, a CD3δ chain, and two CD3ε chains. CD3 epsilon/CD3e 1-27 peptide Protein, Human, Recombinant (hFc & Avi) is expressed in HEK293 mammalian cells with C-hFc-Avi tag. The p... | |||
TMPK-01413 |
H-2K (b) &B2M&OVA (SIINFEKL) Monomer Protein, Mouse, MHC (His & Avi)
H-2K,OVA,MHC,H2-K1 |
Mouse | HEK293 Cells |
Ovalbumin (OVA) has been historically a popular source of such antigens, since OVA can induce both humoral and cellular immune responses based on well-characterised peptide epitopes. The OVA257-264 octapeptide was one of the frst OVA epitopes to be characterised, it has an amino acid sequence SIINFEKL, which is recognised by cytotoxic T lymphocytes. SIINFEKL forms fbrillar assemblies similar to other peptide hydrogels. Te immunoactive properties of this peptide can therefore be related to its se... | |||
TMPJ-00364 |
LRRC32 Protein, Human, Recombinant (hFc)
D11S833E,GARPGarpin,GARP,Garpin |
Human | HEK293 Cells |
Leucine Rich Repeat Containing 32 (LRRC32), also known as Glycoprotein A Repetitions Predominant (GARP), has been postulated as a novel surface marker of activated T(regs). LRRC32 binds directly to the TGF-beta latency associated peptide (LAP) and tethers latent TGF-beta on the surface of activated Treg cells. The presentation of TGF-beta on Tregs contributes to their ability to suppress naïve T cell proliferation. LRRC32 is widely expressed during embryogenesis and on adult platelets. Human LRR... | |||
TMPK-01412 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi)
SARS-CoV-2 epitope,MHC |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPK-01416 |
HLA-B*15:01&B2M&SARS-CoV-2 epitope (NQKLIANQF) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,SARS-CoV-2 epitope |
Human | HEK293 Cells |
HLA-B*15:01 is strongly associated with asymptomatic infection with SARS-CoV-2 and is likely to be involved in the mechanism underlying early viral clearance. T cells from pre-pandemic individuals carrying HLA-B*15:01 were reactive to the immunodominant SARS-CoV-2 S-derived peptide NQKLIANQF, and 100% of the reactive cells displayed memory phenotype. | |||
TMPH-02173 |
TRBC2 Protein, Human, Recombinant (His & Myc)
T cell receptor beta const |
Human | E. coli |
Constant region of T cell receptor (TR) beta chain. Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens. Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracell... | |||
TMPH-02168 |
TRAC Protein, Human, Recombinant (E. coli, His)
T cell receptor alpha chain const... |
Human | E. coli |
Constant region of T cell receptor (TR) alpha chain. Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens. Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracel... | |||
TMPH-02169 |
TRBC1 Protein, Human, Recombinant (His)
T cell receptor beta const |
Human | P. pastoris (Yeast) |
Constant region of T cell receptor (TR) beta chain. Alpha-beta T cell receptors are antigen specific receptors which are essential to the immune response and are present on the cell surface of T lymphocytes. Recognize peptide-major histocompatibility (MH) (pMH) complexes that are displayed by antigen presenting cells (APC), a prerequisite for efficient T cell adaptive immunity against pathogens. Binding of alpha-beta TR to pMH complex initiates TR-CD3 clustering on the cell surface and intracell... | |||
TMPH-03279 |
DPP4/CD26 Protein, Rat, Recombinant (His & SUMO)
Dpp4,Dipeptidyl peptidase IV,DPP IV,CD26,D... |
Rat | E. coli |
Cell surface glycoprotein receptor involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Acts as a positive regulator of T-cell coactivation, by binding at least ADA, CAV1, IGF2R, and PTPRC. Its binding to CAV1 and CARD11 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Its interaction with ADA also regulates lymphocyte-epithelial cell adhesion. In association with FAP is involved in the pericellular ... | |||
TMPH-00550 |
Epstein-Barr virus (strain B95-8) BCRF1 Protein (His & Myc)
20 kDa protein,Viral interleukin-10 homolo... |
EBV | E. coli |
Plays a role in masking infected cells for immune recognition by cytotoxic T-lymphocytes. Down-regulates the expression of the host TAP1 gene (transporter associated with antigen processing), thereby affecting the transport of peptides into the endoplasmic reticulum and subsequent peptide loading by MHC class I molecules. Inhibits IFN-gamma synthesis. Epstein-Barr virus (strain B95-8) BCRF1 Protein (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted m... | |||
TMPJ-00250 |
LAP (TGF-beta 1) Protein, Human, Recombinant (His & Avi), Biotinylated
transforming growth factor β1, |
Human | HEK293 Cells |
Transforming growth factor beta (TGFβ) family members are secreted in inactive complexes with a latency-associated peptide (LAP), a protein derived from the N-terminal region of the TGFβ gene product. Extracellular activation of these complexes is a critical step in regulation of TGFβ function in vivo. The TGFβ1 LAP is a ligand for the integrin αvβ6 and that αvβ6-expressing cells induce spatially restricted activition of TGFβ1. And LAP identifies a novel CD4+/CD25+ regulatory T cell subset with ... | |||
TMPH-03206 |
ITGB8 Protein, Rabbit, Recombinant (His & Myc)
ITGB8,Integrin beta-8 |
Rabbit | E. coli |
Integrin alpha-V:beta-8 (ITGAV:ITGB8) is a receptor for fibronectin. It recognizes the sequence R-G-D in its ligands. Integrin alpha-V:beta-6 (ITGAV:ITGB6) mediates R-G-D-dependent release of transforming growth factor beta-1 (TGF-beta-1) from regulatory Latency-associated peptide (LAP), thereby playing a key role in TGF-beta-1 activation on the surface of activated regulatory T-cells (Tregs). Required during vasculogenesis. ITGB8 Protein, Rabbit, Recombinant (His & Myc) is expressed in E. coli ... | |||
TMPJ-00848 |
NCF1 Protein, Human, Recombinant (His)
Nox-organizing protein 2/SH3 and PX domain-cont... |
Human | E. coli |
Neutrophil cytosol factor 1( NCF1) is a 47 kDa cytosolic subunit of neutrophil NADPH oxidase. This oxidase is characterized as a multicomponent enzyme which is activated to produce superoxide anion. NCF2, NCF1, and a membrane bound cytochrome b558 are required for the activation of the latent NADPH oxidase. The human NCF1 gene encodes a 390 amino acids protein without a signal peptide. The NCF1 gene interacts with other subunits of nicotinamide adenine dinucleotide phosphate-oxidase (NADPH) and ... | |||
TMPH-02275 |
Lck Protein, Human, Recombinant (His)
Proto-oncogene Lck,T cell-specific pro... |
Human | E. coli |
Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules... | |||
TMPJ-01212 |
ULBP-1 Protein, Mouse, Recombinant (His)
RAET1I,ULBP1,NKG2DL1 |
Mouse | HEK293 Cells |
Mouse ULBP1, also known as RAET1I and NKG2DL1, is a member of the ULBP/RAET1 gene family. ULBP1 plays an important role in immune responses, especially in cancer and infectious diseases, and is well-known to bind to NKG2D together with at least ULBP 2 and 3. These proteins are distantly related to major histocompatibility class I (MHC I) molecules, possessing the alpha 1 and alpha 2 Ig-like domains, but lacking the alpha 3 domain. Unlike MHC Class I, they have no capacity to bind peptide or inte... | |||
TMPJ-00047 |
IL-31 Protein, Human, Recombinant
IL-31,Interleukin-31,白介素,白细胞介素,IL31 |
Human | E. coli |
Human Interleukin 31 (IL-31) is a cytokine containing a four-helix bundle structure. It shares several structural and functional characteristics with IL-6, Oncostatin M, LIF, and Cardiotrophin-1. Human IL-31 cDNA encodes a 164 amino acid precursor that contains a 23 amino acid signal peptide and a 141 amino acid mature protein. Human and mouse IL-31 share 24% sequence identity in the mature region. IL-31 is mainly associated with activated T cells and is preferentially expressed by type 2 helper... | |||
TMPJ-01397 |
Siglec-7 Protein,Human,Recombinant(aa 19-353, His)
AIRM1,p75/AIRM1,CD328 antigen,CD328,AIRM-1,siglec-7... |
Human | HEK293 Cells |
Siglecs (sialic acid binding Ig-like lectins) are I-type (Ig-type) lectins belonging to the Ig superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains. Eleven human Siglecs have been cloned and characterized. Human Siglec-7 encodes a 467 amino acid (aa) polypeptide with a hydrophobic signal peptide, an N-terminal Ig-like V-type domain, two Ig-like C2-type domains, a transmembrane region ... | |||
TMPJ-00674 |
RANK/TNFRSF11A Protein, Mouse, Recombinant (His)
Receptor activator of NF-KB,T... |
Mouse | HEK293 Cells |
Receptor activator of NF-κB(RANK,TNFRSF11A) belongs to one member of tumor necrosis factor receptor family.It is a receptor for TNFSF11/RANKL/TRANCE/OPGL. This gene encodes a type 1 membrane protein with a 30 amino acids (aa) signal peptide, 184 aa extracellular region , a 20 aa transmembrane domain and a 391 aa cytoplasmic region. Human and murine RANK share 81% aa identity in their extracellular domains. RANK is ubiquitous highly expressed in trabecular bone, thymus, small intestine, lung, br... | |||
TMPJ-00067 |
BAFFR/TNFRSF13C Protein, Human, Recombinant (His)
BR3,BAFFR,CD268,TNFRSF13C,BAFF R |
Human | HEK293 Cells |
Tumor necrosis factor receptor superfamily, member 13C (TNFRSF13C) also known as B-cell-activating factor receptor (BAFFR) and CD268 antigen, is a member of the tumor necrosis factor receptor superfamily. BAFF promotes the survival of B cells and is essential for B cell maturation. BAFF binds to three TNF receptor superfamily members: B-cell maturation antigen (BCMA/TNFRSF17), transmembrane activator and calcium-modulator and cyclophilin ligand interactor (TACI/TNFRSF13B) and BAFF receptor (BAFF... | |||
TMPH-00775 |
IFN gamma Protein, Goat, Recombinant (His & Myc)
Interferon gamma,IFNG |
Goat | E. coli |
Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation. Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation. Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling components JAK2, JAK1 and STAT1, leading to STAT1 activati... | |||
TMPK-01491 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi), Biotinylated
MHC,HBV,Hepatitis B virus |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01501 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Tetramer Protein, Human, MHC (His & Avi)
MHC,Hepatitis B virus,HBV |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01505 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi), Biotinylated
E7,MHC,HPV16 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01492 |
HLA-A*02:01&B2M&HBV (FLLTRILTI) Monomer Protein, Human, MHC (His & Avi)
Hepatitis B virus,HBV,MHC |
Human | HEK293 Cells |
Hepatitis B virus (HBV), is the leading cause of liver diseases infecting an estimated 240 million persons worldwide. The HBV prevalence rates are variables between different countries, with an high level of endemicity in the south-eastern part of Europe. Seven main HBV-D subgenotypes have been described until now (D1-D7). | |||
TMPK-01504 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Tetramer Protein, Human, MHC (His & Avi)
MHC,HPV16,E7 |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. | |||
TMPK-01506 |
HLA-A*02:01&B2M&HPV16 E7 (YMLDLQPET) Monomer Protein, Human, MHC (His & Avi)
HPV16,E7,MHC |
Human | HEK293 Cells |
HPV16 E7 protein, one of the primary target proteins in molecular targeted therapy for HPV-induced cervical cancer. The affitoxin, ZHPV16E7 affitoxin384 was generated by fusing the modified Pseudomonas Exotoxin A (PE38KDEL) to the HPV16 E7-specific affibody. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38356 |
1,2-Dipalmitoyl-13C-sn-glycero-3-PC
|
||
1,2-Dipalmitoyl-13C-sn-glycero-3-PC is intended for use as an internal standard for the quantification of 1,2-dipalmitoyl-sn-glycero-3-PC by GC- or LC-MS. 1,2-Dipalmitoyl-sn-glycero-3-PC (DPPC) is a zwitterionic glycerophospholipid commonly used in the formation of lipid monolayers, bilayers, and liposomes for use in a variety of applications.1,2,3,4 It has been used in the formation of proteoliposomes for implantation of γ-glutamyl transpeptidase into human erythrocyte membranes.3 Incorporation... |